Metabolic Radiomics for Pretreatment 18F-FDG PET/CT to Characterize Locally Advanced Breast Cancer: Histopathologic Characteristics, Response to Neoadjuvant Chemotherapy, and Prognosis - Wikidata - awgldk - TriplyDB

Metabolic Radiomics for Pretreatment 18F-FDG PET/CT to Characterize Locally Advanced Breast Cancer: Histopathologic Characteristics, Response to Neoadjuvant Chemotherapy, and Prognosis

Metabolic Radiomics for Pretreatment 18F-FDG PET/CT to Characterize Locally Advanced Breast Cancer: Histopathologic Characteristics, Response to Neoadjuvant Chemotherapy, and Prognosis

http://www.wikidata.org/entity/Q33685937

about

[(18)F]FDG PET/CT features for the molecular characterization of primary breast tumors.Radiomics analysis of pre-treatment [F]FDG PET/CT for patients with metastatic colorectal cancer undergoing palliative systemic treatment Predicting the response to neoadjuvant therapy for early-stage breast cancer: tumor-, blood-, and imaging-related biomarkers

P2860

Q38677216-8F237934-5DAC-46B6-AAF9-80A6F7B03F06 Q57170055-9E2758B7-4A53-4CD1-8CD4-FFEB98C08FD3 Q57816466-65967412-547D-46D7-83C9-B01BE4C08EA6

P2860

Metabolic Radiomics for Pretreatment 18F-FDG PET/CT to Characterize Locally Advanced Breast Cancer: Histopathologic Characteristics, Response to Neoadjuvant Chemotherapy, and Prognosis

http://www.wikidata.org/entity/Q33685937

description

2017 nî lūn-bûn

@nan

2017 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Metabolic Radiomics for Pretre ...... nt Chemotherapy, and Prognosis

@ast

Metabolic Radiomics for Pretre ...... nt Chemotherapy, and Prognosis

@en

type

label

Metabolic Radiomics for Pretre ...... nt Chemotherapy, and Prognosis

@ast

Metabolic Radiomics for Pretre ...... nt Chemotherapy, and Prognosis

@en

prefLabel

Metabolic Radiomics for Pretre ...... nt Chemotherapy, and Prognosis

@ast

Metabolic Radiomics for Pretre ...... nt Chemotherapy, and Prognosis

@en

P1433

Q33685937-F4226C6E-6D6C-4FE7-B32F-AF522BC23E84

P1476

Q33685937-97D39B61-FDD3-446F-A61F-08A438B69A10

P2093

Q33685937-024DBBD8-D5B3-4423-8FC2-D8567B045852

Q33685937-B9C984AB-4638-450D-97FC-2F0AD8C26DBD

Q33685937-C14B4547-9C66-4E0D-A261-8E50B10B85A8

Q33685937-F2FD8165-083D-4D5D-A335-423A2ADE38FD

P2860

Q33685937-025AB1C1-1AF6-481B-A0C3-1CF6A2E55DB6

Q33685937-0D566602-066F-41FA-81B8-ABA129B7BB18

Q33685937-0EA29690-950D-4E00-B8E3-ED51B82F185C

Q33685937-12722408-C7E0-4C48-AC3F-81D19586F887

Q33685937-19A35C80-9DDB-460A-9847-BABEBE452167

Q33685937-1D86DE38-B8E6-4942-BAD6-9D998E23419E

Q33685937-2F0B2FEE-66F0-4C17-9DA6-27272592261F

Q33685937-3F3CFB7A-5775-49F7-A2A5-1567DDF99EA6

Q33685937-44803842-257E-4B8F-8166-636228EA1EEB

Q33685937-4D32F333-CDB3-4CA5-9CD3-DBA394F3768F

P2888

Q33685937-C5B2749C-CF53-4267-948E-74122310E760

P304

Q33685937-67FB1BF1-C084-4276-903B-3F1554ABD704

P31

Q33685937-195972AE-C683-4591-9196-360124B89D5C

P356

Q33685937-1CFD6838-4F2B-42A8-B69B-4203F0215938

P407

Q33685937-E83C1A06-F73D-41B9-8471-7C1D3937403F

P433

Q33685937-5F0A632E-1DEC-4DD7-BE70-AEC6F48AFB05

P478

Q33685937-2BBCDAF7-8671-4B10-A360-5228A7784006

P50

Q33685937-0943CEDE-55B8-45BC-85AF-A351D35578C6

P577

Q33685937-23E3D5F8-AF59-43B1-93AF-3A5AC093EDCF

P6179

Q33685937-5DC31D71-0AB2-4F9B-90D8-F9A9AE3186FA

P698

Q33685937-792F5BAD-0E61-4B88-BE2F-83F749FD48A1

P932

Q33685937-7DCB802C-A4F3-48DA-9F09-DBDC626EA0F6

P356

S41598-017-01524-7

P1433

Scientific Reports

P1476

Metabolic Radiomics for Pretre ...... nt Chemotherapy, and Prognosis

@en

P2093

Eun-Kyu Kim

http://www.w3.org/2001/XMLSchema#string

Ho-Young Lee

http://www.w3.org/2001/XMLSchema#string

Ji-In Bang

http://www.w3.org/2001/XMLSchema#string

Sohyun Park

http://www.w3.org/2001/XMLSchema#string

P2860

Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach

Non-small cell lung cancer: identifying prognostic imaging biomarkers by leveraging public gene expression microarray data--methods and preliminary results

A new initiative on precision medicine

Characterization of PET/CT images using texture analysis: the past, the present… any future?

Texture analysis of medical images.

Do clinical, histological or immunohistochemical primary tumour characteristics translate into different (18)F-FDG PET/CT volumetric and heterogeneity features in stage II/III breast cancer?

The effect of small tumor volumes on studies of intratumoral heterogeneity of tracer uptake.

Intratumor heterogeneity characterized by textural features on baseline 18F-FDG PET images predicts response to concomitant radiochemotherapy in esophageal cancer

Are pretreatment 18F-FDG PET tumor textural features in non-small cell lung cancer associated with response and survival after chemoradiotherapy?

18F-FDG PET uptake characterization through texture analysis: investigating the complementary nature of heterogeneity and functional tumor volume in a multi-cancer site patient cohort.

P2888

s41598-017-01524-7

P304

1556

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-01524-7

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-05-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1085208556

http://www.w3.org/2001/XMLSchema#string

P698

28484211

http://www.w3.org/2001/XMLSchema#string

P932

5431555

http://www.w3.org/2001/XMLSchema#string